|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
US3957965A
(en)
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1257162A
(enExample)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
US4919915A
(en)
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
DE69034007T2
(de)
|
1989-04-28 |
2003-05-08 |
Riker Laboratories Inc., Northridge |
Inhalationsvorrichtung für Trockenpulver
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
CA2174583A1
(en)
|
1995-05-05 |
1996-11-06 |
Alexander Chucholowski |
Sulfuric acid esters of sugar alcohols
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
ATE239447T1
(de)
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
In verneblern verwendbare, stabilisierte zubereitungen
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
NZ508663A
(en)
|
1998-06-12 |
2003-02-28 |
Microdose Technologies Inc |
A dry powder inhaler with a vibrator to deaggregate the powder and feedback control for controlling dosing
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
CA2347856C
(en)
|
1998-11-13 |
2009-02-17 |
Jagotec Ag |
Dry powder for inhalation
|
|
OA11740A
(en)
|
1998-12-24 |
2005-05-13 |
Janssen Pharmaceutica Nv |
Controlled release galantamine composition.
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US20020107173A1
(en)
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
EE200200444A
(et)
|
2000-02-21 |
2003-12-15 |
Pharmexa A/S |
Meetod autoloogse beeta-amüloidvaigu in vivo mahasurumiseks, amüloidogeense polüpeptiidi analoog, seda kodeeriv nukleiinhappefragment ning kasutamineimmunogeense kompositsiooni valmistamiseks
|
|
WO2001078721A1
(en)
|
2000-04-13 |
2001-10-25 |
Mayo Foundation For Medical Education And Research |
Aβ42 LOWERING AGENTS
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
KR20040058111A
(ko)
|
2001-04-23 |
2004-07-03 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
아밀로이드 플라크 응집 억제제 및 진단 영상화제
|
|
AU2002352974A1
(en)
|
2001-11-29 |
2003-06-10 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
|
AU2003228963B2
(en)
|
2002-05-10 |
2009-01-22 |
Oriel Therapeutics, Inc. |
Dry powder inhalers
|
|
EP1601379A1
(en)
*
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
WO2004071531A1
(en)
|
2003-02-13 |
2004-08-26 |
Licentia Oy |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
WO2005044187A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
US20070093457A1
(en)
|
2004-02-11 |
2007-04-26 |
Nadir Arber |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
WO2006001877A2
(en)
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
HUE058227T2
(hu)
|
2004-04-23 |
2022-07-28 |
Cydex Pharmaceuticals Inc |
DPI készítmény, amely szulfoalkil-éter-ciklodextrint tartalmaz
|
|
EP1789057B1
(en)
|
2004-08-30 |
2010-02-24 |
Seo Hong Yoo |
Neuroprotective effect of solubilized udca in focal ischemic model
|
|
AU2005302452B2
(en)
*
|
2004-11-01 |
2010-12-09 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in Amyotrophic Lateral Sclerosis
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
ZA200708857B
(en)
|
2005-04-22 |
2009-01-28 |
Genentech Inc |
Method for treating dementia or alzheimer's disease with a CD30 antibody
|
|
AU2006251832A1
(en)
|
2005-05-27 |
2006-11-30 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
WO2007102059A1
(en)
|
2006-03-06 |
2007-09-13 |
Pfizer Japan Inc. |
Sulfonyl benzimidazole derivatives
|
|
KR20090026247A
(ko)
|
2006-03-09 |
2009-03-12 |
와라타 파마수티컬즈, 인크. |
단백질 응집 장애의 치료를 위한 사이클로헥산 폴리알콜 제형
|
|
US7700616B2
(en)
|
2006-05-08 |
2010-04-20 |
Molecular Neuroimaging, Llc. |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
WO2008034244A1
(en)
|
2006-09-21 |
2008-03-27 |
Waratah Pharmaceuticals Inc. |
The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases
|
|
EP2091566A4
(en)
|
2006-11-24 |
2011-07-06 |
Waratah Pharmaceuticals Inc |
COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
|
|
US8772508B2
(en)
|
2007-04-18 |
2014-07-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
|
EP2146746A4
(en)
|
2007-04-18 |
2011-03-23 |
Janssen Alzheimer Immunotherap |
PREVENTIVE AND TREATING ZEREBRALER AMYLOID ANGIOPATHY
|
|
WO2008134618A2
(en)
|
2007-04-27 |
2008-11-06 |
The General Hospital Corporation |
Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders
|
|
EP2173380A4
(en)
|
2007-07-13 |
2011-08-31 |
Abbott Biotech Ltd |
METHOD AND COMPOSITIONS FOR PULMONARY ADMINISTRATION OF A TNFa HEMMER
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
EP3231804B1
(en)
|
2008-03-21 |
2021-03-03 |
The General Hospital Corporation |
Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
|
|
WO2009133128A1
(en)
|
2008-04-29 |
2009-11-05 |
Pharnext |
Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
|
|
EP2379533A4
(en)
|
2009-01-22 |
2012-07-04 |
Raqualia Pharma Inc |
N-SUBSTITUTED SATURATED HETEROCYCLIC SULFON COMPOUNDS WITH CB2 RECEPTOR AGONIST EFFECT
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
CN105061376A
(zh)
*
|
2009-01-29 |
2015-11-18 |
通用医疗公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
|
SG173705A1
(en)
|
2009-03-05 |
2011-09-29 |
Abbott Lab |
Il-17 binding proteins
|
|
TW201036972A
(en)
|
2009-03-11 |
2010-10-16 |
Plexxikon Inc |
Compounds and uses thereof
|
|
JP2012520883A
(ja)
|
2009-03-16 |
2012-09-10 |
アイピントゥル，エルエルシー |
アルツハイマー病及び骨粗鬆症の治療並びに老化の軽減
|
|
ES2457442T3
(es)
|
2009-05-08 |
2014-04-25 |
Pari Pharma Gmbh |
Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
|
|
AU2010281524A1
(en)
*
|
2009-08-06 |
2012-02-23 |
Neuraltus Pharmaceuticals, Inc. |
Treatment of macrophage-related disorders
|
|
BR122019022612B8
(pt)
|
2009-09-24 |
2021-07-27 |
Wista Lab Ltd |
forma e de mono-hidrato de cloreto de metiltionínio, seu processo de preparação, e composição farmacêutica
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
US20110262442A1
(en)
|
2009-11-06 |
2011-10-27 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
BR112012012999A2
(pt)
|
2009-11-30 |
2019-04-02 |
Aptalis Pharmatech Inc |
Composição farmacêutica, e composição de tablete de desintegração oral (odt) outablete de dispersão rápida (rdt)
|
|
US20110256064A1
(en)
|
2010-04-16 |
2011-10-20 |
Ac Immune, S.A. |
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
BR112013003110A2
(pt)
*
|
2010-08-12 |
2016-06-28 |
Revalesio Corp |
composições e métodos para tratamento de taupatia
|
|
EP2621494B1
(en)
|
2010-09-30 |
2018-11-07 |
Chiesi Farmaceutici S.p.A. |
Use of magnesium stearate in dry powder formulations for inhalation
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
AU2011358840B2
(en)
|
2011-02-11 |
2017-05-04 |
TauRx Therapeutics Management Ltd |
Phenothiazine diaminium salts and their use
|
|
US9730921B2
(en)
|
2012-03-27 |
2017-08-15 |
Duke University |
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
|
|
CA2870158C
(en)
|
2012-05-25 |
2017-10-24 |
Xlear, Inc. |
Xylitol-based anti-mucosal compositions and related methods and compositions
|
|
AU2013308519A1
(en)
*
|
2012-08-31 |
2015-04-09 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of Alzheimer's disease
|
|
EP2913053A4
(en)
|
2012-10-23 |
2016-05-25 |
Teijin Pharma Ltd |
THERAPEUTIC OR PROPHYLACTIC AGENT FOR TUMOR LYING SYNDROME
|
|
EP2911664B1
(en)
*
|
2012-10-25 |
2019-05-08 |
The General Hospital Corporation |
Combination therapies for the treatment of alzheimer's disease and related disorders
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
JP2016534976A
(ja)
*
|
2013-05-23 |
2016-11-10 |
アズセラピーズ インコーポレイテッド |
クロモリンを送達する方法
|
|
CN104288168B
(zh)
*
|
2013-07-17 |
2017-08-18 |
吉林敖东洮南药业股份有限公司 |
延龄草苷在制备用于治疗和/或预防小胶质细胞介导的疾病的药物中的用途
|
|
AU2014340182B2
(en)
|
2013-10-22 |
2019-05-23 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
EP3653207A1
(en)
|
2014-02-10 |
2020-05-20 |
Respivant Sciences GmbH |
Mast cell stabilizers treatment for systemic disorders
|
|
EP3725311A1
(en)
*
|
2014-02-10 |
2020-10-21 |
Respivant Sciences GmbH |
Methods for the treatment of lung diseases with mast cell stabilizers
|
|
EA201791110A1
(ru)
|
2014-11-21 |
2017-11-30 |
Биохэвен Фармасьютикэл Холдинг Компани Лтд. |
Сублингвальное введение рилузола
|
|
US11723864B2
(en)
|
2015-05-29 |
2023-08-15 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
US20180311236A1
(en)
*
|
2015-10-28 |
2018-11-01 |
Ab Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
CN114042061A
(zh)
|
2015-11-19 |
2022-02-15 |
通用医院有限公司 |
包含色甘酸的组合物在制备用于治疗非遗忘性轻度认知障碍的药物中的用途
|
|
US20180344682A1
(en)
|
2015-11-23 |
2018-12-06 |
Aztherapies, Inc. |
Compositions and methods for treating ischemic stroke
|
|
SG11201808106YA
(en)
*
|
2016-03-25 |
2018-10-30 |
Ab Science |
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
|
|
CA3033079A1
(en)
|
2016-08-31 |
2018-03-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
|
ES2988617T3
(es)
|
2016-09-08 |
2024-11-21 |
Emergo Therapeutics Inc |
Norketotifeno para el tratamiento de la hipercitocinemia y las infecciones virales
|
|
KR20210070232A
(ko)
|
2017-07-20 |
2021-06-14 |
아즈테라피즈 인코포레이티드 |
크로몰린 나트륨 및 이부프로펜의 분말화된 제형
|
|
CN108164409B
(zh)
|
2018-01-24 |
2021-06-18 |
温州医科大学 |
一种2-亚苄基-1-茚酮类似物及应用
|
|
US20210059977A1
(en)
|
2018-04-09 |
2021-03-04 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotrophic lateral sclerosis and related disorders
|
|
CN108403708B
(zh)
|
2018-05-22 |
2019-06-14 |
滨州医学院 |
秦皮苷在制备预防或治疗急性呼吸窘迫综合征药物中的应用
|
|
CA3105392A1
(en)
|
2018-07-02 |
2020-01-09 |
The General Hospital Corporation |
Powdered formulations of cromolyn sodium and .alpha.-lactose
|
|
KR20210071974A
(ko)
|
2018-09-05 |
2021-06-16 |
더 제너럴 하스피탈 코포레이션 |
사이토카인 방출 증후군을 치료하는 방법
|
|
EP3893945A4
(en)
|
2018-12-10 |
2022-11-30 |
The General Hospital Corporation |
CROMOGLYC ESTERS AND THEIR USES
|
|
US12458622B2
(en)
|
2020-04-06 |
2025-11-04 |
The General Hospital Corporation |
Methods of treatment of coronavirus-induced inflammation conditions
|
|
IL298673A
(en)
|
2020-06-04 |
2023-01-01 |
Massachusetts Gen Hospital |
Methods for treating the corona virus infection
|
|
WO2022146914A1
(en)
|
2020-12-28 |
2022-07-07 |
The General Hospital Corporation |
Cromolyn derivatives and uses thereof
|